Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Ivan P. Uray"'
Autor:
Guang Peng, Gordon B. Mills, Xuetong Shen, Powel H. Brown, Xiangwei Wu, Ivan P. Uray, Ie-Ming Shih, Qianxing Mo, Zhenlin Ju, Prabodh Kapoor, Li Lan, Lin Yang, Wei Zhang, Leizhen Wei, Yang Peng, Jianfeng Shen
Supplementary Figure 1. Proteomic analysis of ATR-interacting proteins. Supplementary Figure 2. ARID1A interacts with ATR in MDA-MB-231 Cells. Supplementary Figure 3. ARID1A recruitment to I-SceI-induced DSBs analyzed by ChIP assay. Supplementary Fig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d07a870a17cd31c051d3528aa6767a
https://doi.org/10.1158/2159-8290.22531061.v1
https://doi.org/10.1158/2159-8290.22531061.v1
Autor:
Guang Peng, Gordon B. Mills, Xuetong Shen, Powel H. Brown, Xiangwei Wu, Ivan P. Uray, Ie-Ming Shih, Qianxing Mo, Zhenlin Ju, Prabodh Kapoor, Li Lan, Lin Yang, Wei Zhang, Leizhen Wei, Yang Peng, Jianfeng Shen
Supplementary Figure Legends from ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc24c0844b1d005e89d312c96c0d4ca
https://doi.org/10.1158/2159-8290.22531064
https://doi.org/10.1158/2159-8290.22531064
Autor:
Guang Peng, Gordon B. Mills, Xuetong Shen, Powel H. Brown, Xiangwei Wu, Ivan P. Uray, Ie-Ming Shih, Qianxing Mo, Zhenlin Ju, Prabodh Kapoor, Li Lan, Lin Yang, Wei Zhang, Leizhen Wei, Yang Peng, Jianfeng Shen
Supplementary Methods from ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1273a92d4d40214e7d4da6b0e27666
https://doi.org/10.1158/2159-8290.22531058
https://doi.org/10.1158/2159-8290.22531058
Autor:
Tibor Hortobágyi, Almos Klekner, Péter Árkosy, Gábor Zahuczky, László Szivos, Ivan P. Uray, Adrienn Jenei, László Bognár, József Virga
Publikováno v:
Ideggyógyászati szemle. 73:317-325
Background and purpose Glioblastoma is the most common malignant CNS tumor, its surgical removal is hindered by the tumors invasive nature, while current anti-tumor therapies show limited effectiveness - mean overall survival is 16-24 months. Some pa
Autor:
Adam T Szafran, Sean Hartig, Huiying Sun, Ivan P Uray, Maria Szwarc, Yuqing Shen, Sanjay N Mediwala, Jennifer Bell, Michael J McPhaul, Michael A Mancini, Marco Marcelli
Publikováno v:
PLoS ONE, Vol 4, Iss 12, p e8179 (2009)
Androgen insensitivity syndrome (AIS) is a rare disease associated with inactivating mutations of AR that disrupt male sexual differentiation, and cause a spectrum of phenotypic abnormalities having as a common denominator loss of reproductive viabil
Externí odkaz:
https://doaj.org/article/1a8364735b444918a63228b67a212ef0
Autor:
Loretta László, Ivan P. Uray
Publikováno v:
Methods in Molecular Biology ISBN: 9781493995844
Retinoids and rexinoids directly and selectively activate their nuclear receptors, resulting in changes in the transcript levels of their target genes. Consequently, quantitating mRNA levels transcribed from cognate target genes is the most accurate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40b5e65570efd4ae7ebed3b0f819d77f
https://doi.org/10.1007/978-1-4939-9585-1_16
https://doi.org/10.1007/978-1-4939-9585-1_16
Autor:
Károly Jambrovics, Pál Botó, Attila Pap, Zsolt Sarang, Zsuzsanna Kolostyák, Zsolt Czimmerer, Istvan Szatmari, László Fésüs, Iván P. Uray, Zoltán Balajthy
Publikováno v:
Cell Death and Disease, Vol 14, Iss 3, Pp 1-10 (2023)
Abstract Atypically expressed transglutaminase 2 (TG2) has been identified as a poor prognostic factor in a variety of cancers. In this study, we evaluated the contribution of TG2 to the prolonged cell survival of differentiated acute promyelocytic l
Externí odkaz:
https://doaj.org/article/2af418809b3c4062a29a52c240c93479
Autor:
Li Lan, Gordon B. Mills, Prabodh Kapoor, Ivan P. Uray, Xuetong Shen, Guang Peng, Qianxing Mo, Zhenlin Ju, Jianfeng Shen, Yang Peng, Xiangwei Wu, Ie Ming Shih, Leizhen Wei, Powel H. Brown, Lin Yang, Wei Zhang
Publikováno v:
Cancer discovery, vol 5, iss 7
ARID1A, SWI/SNF chromatin remodeling complex subunit, is a recently identified tumor suppressor that is mutated in a broad spectrum of human cancers. Thus, it is of fundamental clinical importance to understand its molecular functions and determine w
Autor:
Wei Tu, Lulu Wang, Guang Peng, Jianfeng Shen, Powel H. Brown, Xiangdong Peng, Yang Peng, Ivan P. Uray, Lihong Zhang
Investigation of natural products is an attractive strategy to identify novel compounds for cancer prevention and treatment. Numerous studies have shown the efficacy and safety of natural products, and they have been widely used as alternative treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538f17fc9010a11c7a5372617eb9a85a
https://europepmc.org/articles/PMC5909195/
https://europepmc.org/articles/PMC5909195/
Autor:
Hui Ju Hsieh, Lihong Zhang, Powel H. Brown, Jianfeng Shen, Ivan P. Uray, Yuping Yin, Yang Peng, Qian Shen, Kaixiong Tao, Lulu Wang, Guang Peng
Publikováno v:
SLAS discovery : advancing life sciences RD. 22(7)
ARID1A, a component of the chromatin remodeling complex SWI/SNF, is an evolutionarily conserved complex that uses the energy of adenosine triphosphate hydrolysis to remodel chromatin structure and functions as a master regulator of gene transcription